Spasfon 4ml Injection (Antispasmodic)

Drug Class: Antispasmodic — Direct Smooth Muscle Relaxant | Form: Intramuscular (IM) / Intravenous (IV) Injection | Prescription Status: Prescription Only (Rx) — DRAP Registered

What is Spasfon 4ml Injection?

Spasfon 4ml Injection is a prescription antispasmodic medicine used to rapidly relieve acute, severe pain caused by involuntary smooth muscle spasms in the internal organs — particularly the gastrointestinal tract, bile ducts, and urinary tract. Unlike NSAIDs or opioid analgesics that target pain signals in the nervous system, Spasfon works directly on the smooth muscle tissue of cramping internal organs — relaxing the spasm at its source and providing fast relief from the intense colicky pain it causes.

Smooth muscle spasm pain — known medically as colic (درد قولنج) — is characteristically severe, wave-like, and often debilitating. It is caused by abnormal, forceful contractions of the hollow muscular organs of the body — the intestines, bile ducts, ureters, and uterus — often triggered by obstruction, irritation, or inflammation. Spasfon injection directly targets and relaxes this abnormal muscle contraction, providing rapid relief in acute clinical situations where immediate pain control is required and oral administration is not fast or appropriate enough.

The injectable formulation achieves rapid onset of action — delivering the antispasmodic agent directly into the bloodstream and reaching cramping smooth muscle tissue within minutes. It is used in emergency departments, hospital wards, and clinical settings across Pakistan for conditions including renal colic, biliary colic, severe menstrual cramps, and labour pain management. It must be administered exclusively by a qualified doctor or nurse.

What is Spasfon 4ml Injection Used For?

Spasfon 4ml Injection is prescribed for the acute treatment of the following conditions involving smooth muscle spasm:

• Renal colic — severe, intense pain caused by kidney stones passing through the ureter (گردے کی پتھری کا شدید درد) — one of the most common and important indications; ureteral smooth muscle spasm is the primary driver of renal colic pain
• Biliary colic — sudden severe right upper abdominal pain caused by gallstones obstructing the bile duct and triggering biliary smooth muscle spasm (پتے کی پتھری کا درد)
• Gastrointestinal spasm — acute cramping abdominal pain caused by intestinal smooth muscle spasm in conditions including irritable bowel syndrome, gastroenteritis, and post-operative ileus (آنتوں کی اینٹھن)
• Dysmenorrhoea (menstrual cramps) — severe period pain driven by uterine smooth muscle spasm and cramping (شدید ماہواری درد) — particularly when oral antispasmodics have not provided adequate relief
• Labour pain — smooth muscle spasm component of uterine contractions during labour — used for pain relief and to reduce excessive uterine cramping during delivery
• Ureteric spasm — painful spasm of the ureter following urological procedures, stone passage, or catheterisation
• Oesophageal spasm — acute painful spasm of the oesophageal smooth muscle causing severe chest pain mimicking cardiac pain
• Functional abdominal pain — acute cramping abdominal pain of functional origin where smooth muscle spasm is the underlying mechanism

How Does Spasfon 4ml Injection Work?

Spasfon acts as a direct smooth muscle relaxant — working directly on the smooth muscle cells of hollow organs rather than through the nervous system or pain-signalling pathways.

The active component of Spasfon acts on the smooth muscle cells lining the walls of hollow internal organs by inhibiting the mechanisms that cause these cells to contract abnormally. In normal physiology, smooth muscle in internal organs contracts and relaxes in a coordinated, regulated manner to move contents through the organ — such as urine through the ureter or bile through the bile duct. When obstruction, irritation, or abnormal signalling causes these muscles to contract violently and uncontrollably — a spasm — the result is severe colicky pain.

Spasfon interrupts this spasm cycle through two complementary mechanisms:

Phosphodiesterase inhibition — increases intracellular levels of cyclic AMP (cAMP) inside smooth muscle cells; elevated cAMP activates pathways that directly inhibit muscle contraction and promote muscle relaxation

Calcium channel blocking effect — reduces the influx of calcium ions into smooth muscle cells; since calcium is the essential trigger for muscle contraction, reducing its availability inside cells significantly decreases the force and frequency of muscle contractions

The combined result is selective relaxation of spasming smooth muscle — reducing the intensity and frequency of abnormal contractions without affecting cardiac muscle or skeletal muscle. This directly relieves the colicky pain at its source rather than simply blocking pain signals.

When administered by injection, Spasfon reaches smooth muscle tissue within minutes — making it significantly faster than any oral antispasmodic formulation for acute severe colic pain.

Dosage and Administration

⚠️ Spasfon 4ml Injection must be prescribed by a qualified doctor and administered by a trained doctor or nurse only. Never attempt self-administration. Dosing must always be individualised based on clinical assessment and indication.

Administration Guidelines:

• For IV administration — inject slowly over at least 3 to 5 minutes as a slow IV push, or dilute in compatible IV fluid and administer as a short infusion — never as a rapid bolus
• For IM administration — inject deep into a large muscle such as the upper outer buttock with careful site rotation
• The patient should be in a lying-down position during IV administration — Spasfon can cause a transient drop in blood pressure, particularly with rapid IV injection
• Monitor blood pressure during and immediately after IV administration
• Transition to oral Spasfon tablets or syrup as soon as the acute episode is controlled and oral intake is possible

Active Ingredient

The exact active ingredient and strength per ampoule should be confirmed from the product label or official prescribing information — common formulations contain Phloroglucinol with or without Trimethylphloroglucinol as the antispasmodic agent.

Who Should NOT Receive Spasfon 4ml Injection?

Do not administer if the patient:

• Is allergic to Phloroglucinol, Trimethylphloroglucinol, or any other ingredient in the formulation
• Has hypotension — existing low blood pressure is a contraindication, particularly for IV use, as Spasfon can further reduce blood pressure
• Is a child below the age specified in the prescribing information — paediatric dosing must be confirmed by a paediatrician

Always inform the treating doctor before administration if the patient has:

• Cardiovascular disease or cardiac arrhythmias — haemodynamic monitoring is recommended during IV use
• Severe liver or kidney disease — metabolism and elimination may be affected; dose adjustment may be required
• Concurrent use of other medicines affecting blood pressure — additive hypotensive effects are possible
• Is pregnant — Spasfon is used during labour under obstetric supervision; use in earlier pregnancy requires careful medical assessment
• Is breastfeeding — consult the treating doctor before administration

Side Effects

Spasfon 4ml Injection is generally well tolerated. Side effects are uncommon when administered correctly at the recommended dose.

Common Side Effects:

• Mild transient drop in blood pressure (hypotension) — particularly with IV administration; more pronounced with rapid injection; resolved by lying the patient flat
• Mild dizziness or lightheadedness — related to the transient blood pressure effect
• Mild nausea during or after injection
• Warmth or flushing sensation during IV administration
• Mild injection site discomfort with IM use

Serious Side Effects — Inform Medical Team Immediately:

• Significant hypotension — marked drop in blood pressure causing dizziness, weakness, or collapse — more likely with rapid IV injection or in volume-depleted patients; requires immediate clinical intervention
• Severe allergic reaction — sudden widespread rash, hives, swelling of the face, lips, tongue or throat, difficulty breathing — emergency treatment required immediately (یہ طبی ہنگامی صورتحال ہے)
• Cardiac arrhythmia — irregular or abnormally rapid heartbeat during IV administration — monitor cardiac status during infusion in at-risk patients
• Syncope (fainting) — particularly after rapid IV administration in upright patients — always administer with the patient lying down

If any serious side effect occurs during or after injection, the medical team must be informed and emergency measures initiated immediately.

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place protected from direct light
• Do not freeze — freezing may alter solution integrity
• Keep in original packaging until immediately before use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Inspect every ampoule before use — solution must be clear and free of visible particles or discolouration; discard if abnormal
• Use immediately once opened — do not store a partially used ampoule
• Do not use after the expiry date on the ampoule or outer carton

Frequently Asked Questions

How is Spasfon different from Diclofenac injection for renal colic?

Both Spasfon and Diclofenac injection are used for renal colic but work through completely different mechanisms — and they are frequently used together for superior pain relief. Diclofenac is an NSAID that reduces prostaglandin production — decreasing inflammation around the obstructed ureter and reducing the prostaglandin-mediated component of ureteral spasm. Spasfon works directly on ureteral smooth muscle cells to relax the spasm itself — independent of prostaglandins or inflammation. Because they target different components of renal colic pain, their combination provides more complete and faster relief than either medicine alone. Your doctor will determine whether one or both are appropriate based on the severity of the colic and the patient's clinical profile.

Why must the patient lie down during Spasfon IV injection?

Spasfon causes direct smooth muscle relaxation — and smooth muscle is present not only in internal organs but also in the walls of blood vessels. Relaxation of vascular smooth muscle causes blood vessels to widen (vasodilation), which can produce a transient drop in blood pressure. When a patient is upright, this blood pressure drop can reduce blood flow to the brain — causing dizziness, lightheadedness, or fainting (syncope). When the patient is lying flat, blood pressure is more evenly distributed and the brain continues to receive adequate blood flow even with mild vasodilation. For this reason, lying the patient down before and during IV administration is a standard safety precaution — not optional.

Is Spasfon Injection safe to use during pregnancy and labour?

Spasfon is widely used during labour in obstetric settings to help manage uterine spasm and smooth muscle cramping during delivery. It is considered one of the safer antispasmodic options in this context under obstetric supervision because it works directly on smooth muscle without significant effects on the nervous system or fetal circulation. However, use during early pregnancy should only occur under explicit medical guidance when the benefit clearly outweighs any theoretical risk. The decision to use Spasfon at any stage of pregnancy must always be made by the treating obstetrician based on individual clinical assessment.

Can Spasfon Injection be combined with other painkillers for severe colic?

Yes — combination analgesia is standard practice for severe renal and biliary colic. Spasfon is frequently combined with NSAIDs (Diclofenac injection) and sometimes with opioid analgesics (Pethidine) in emergency departments for severe colicky pain. Because these medicines work through different mechanisms — Spasfon relaxing the muscle spasm directly, NSAIDs reducing prostaglandin-mediated inflammation, and opioids modifying central pain perception — their combination provides additive and more complete pain relief than any single agent alone. Your treating doctor will select the appropriate combination based on pain severity, clinical setting, and the patient's individual contraindications.

How quickly does Spasfon Injection start working?

When administered intravenously, Spasfon begins acting within 2 to 5 minutes — as it reaches smooth muscle tissue almost immediately through the bloodstream. Patients typically notice a significant reduction in spasm intensity within 5 to 10 minutes of IV administration. Intramuscular administration is slightly slower — onset is typically within 10 to 20 minutes as the medicine is absorbed from the injection site into the bloodstream. This speed of action makes the injectable formulation particularly valuable in acute emergency situations where rapid relief from severe colicky pain is the immediate clinical priority.

When should a patient transition from Spasfon Injection to oral Spasfon?

The transition from injectable to oral Spasfon should occur as soon as the acute severe spasm episode is adequately controlled and the patient can comfortably take oral medicines. For renal colic, once the acute pain crisis is managed with the injection, oral Spasfon tablets can be continued to manage residual ureteral spasm as the stone continues to pass. The treating doctor will determine the appropriate timing and dose for transitioning to the oral form based on the patient's clinical response, the underlying cause of the spasm, and whether the precipitating cause — such as a kidney stone — has been fully resolved.

---

⚕️ Medical Disclaimer: This product description is provided for general informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Spasfon 4ml Injection is a prescription-only medicine that must be administered exclusively by qualified healthcare professionals. Always administer with the patient lying down. Report any significant blood pressure drop, allergic reaction, or cardiac symptoms to the medical team immediately.

---

DRAP Registered | Prescription Required (Rx) | Administer with patient lying down — slow IV injection only — never rapid bolus — transition to oral form as soon as clinically appropriate